2nd International Symposium on Radionuclide Therapy and Radiopharmaceutical Dosimetry

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

2nd International Symposium on Triglycerides and HDL

Lipoprotein subclasses Robert S. Rosenson (Chicago IL) discussed lipoprotein subclasses, inflammation, and cardiovascular disease (CVD) risk in the metabolic syndrome. Insulin resistance impairs VLDL particle clearance, leading to greater interchange of core triglyceride from VLDL with LDL and HDL, with LDL and HDL triglyceride enrichment leading both to become substrates for hepatic lipase, re...

متن کامل

XV International symposium on solid state dosimetry.

submissions due June 30, 2016 Full papers due: September 17, 2016 Symposium presentation September 24-28, 2016 All details: http://smid.org.mx More information: Dr. Juan Azorín Nieto Chair Ms. Francisca Rivera [email protected] [email protected] Universidad Autónoma Metropolitana-Iztapalapa Departamento de Física Av. San Rafael Atlixco 186 Col. Vicentina 09340 Ciudad de México MEXICO Tel. 52-...

متن کامل

2nd International Symposium on TURBULENCE, HEAT AND MASS TRANSFER

Generation of vortices enhances heat transfer by swirl, flow destabilization and development of viscous layers. They may increase heat transfer by several hundred percent. Prior to the use of vortices to influence heat transfer it must be known how different vortices are generated and controlled, and how they interact with the base flow and temperature field. To select the most appropriate vort...

متن کامل

2nd International Symposium on triglycerides and HDL: metabolic syndrome.

This is the first of two articles summarizing the 2nd International Symposium on Triglycerides and HDL, organized by the Giovanni Lorenzini Medical Foundation and held in New York, New York, 14–17 July 2005. Anthony Gotto (New York, NY) gave an overview of the “evolving story” of HDL and triglycerides in cardiovascular disease (CVD) prevention. He noted that statins only reduce clinical events ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Cancer Biotherapy and Radiopharmaceuticals

سال: 2007

ISSN: 1084-9785,1557-8852

DOI: 10.1089/cbr.2007.300